title: Induction of a cytoplasmic activator of DNA synthesis in lymphocytes is mediated through a membrane-associated protein kinase.
abstract: We have shown previously that cytoplasmic extracts from actively dividing lymphoid cells are capable of inducing DNA synthesis in isolated nuclei. One of the factors involved in this activity, ADR, appears to be a greater than 90 kDa heat-labile protease. Cytoplasmic extracts prepared from nonproliferating lymphocytes express little to no ADR activity. However, ADR activity can be generated in these extracts by brief exposure to a membrane-enriched fraction of spontaneously proliferating, leukemic human T lymphoblastoid (MOLT-4) cells. This suggests that ADR activity is present in the resting cytoplasm in an inactive or precursor form. This in vitro generation of ADR activity can be inhibited in a dose-dependent manner by the isoquinolinesulfonamide derivative, H-7 (1-(5-isoquinoline-sulfonyl)-2-methylpiperazine dihydrochloride), an inhibitor of both cyclic adenosine monophosphate (cAMP)-dependent protein kinases and protein kinase C (PKC). However, more specific inhibitors of cAMP-dependent protein kinases, including N-[( 2-methylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride (H8) and N-(2-gua-nidinoethyl)-5-isoquinolinesulfonamide (HA-1004), had little to no effect on the in vitro generation of ADR activity. Furthermore, membranes from MOLT-4 cells depleted of PKC by long-term exposure (24 h) to phorbol esters and calcium ionophores were unable to induce ADR activity in resting peripheral blood lymphocytes extracts. The results of these studies suggest 1) ADR activity is present in resting cell cytoplasm in an inactive or precursor form; and 2) ADR activity can be induced in this resting cytoplasm through a mechanism involving a membrane-associated protein kinase, possibly PKC. The ability of alkaline phosphatase to deplete the activity of preformed ADR suggests the possibility that ADR itself is phosphoprotein.
authors.affiliation: Department of Pathology and Laboratory Medicine, Hahnemann University School of Medicine, Philadelphia, Pennsylvania 19102.
authors.forename: M V
authors.initials: MV
authors.lastname: Autieri
authors.forename: K L
authors.initials: KL
authors.lastname: Fresa
authors.forename: F D
authors.initials: FD
authors.lastname: Coffman
authors.forename: M E
authors.initials: ME
authors.lastname: Katz
authors.forename: S
authors.initials: S
authors.lastname: Cohen
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000469:Alkaline Phosphatase / Q000378:metabolism; D000595:Amino Acid Sequence; D007611:Aprotinin / Q000494:pharmacology; D002467:Cell Nucleus / Q000378:metabolism; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008565:Membrane Proteins / Q000378:metabolism*; D008566:Membranes / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism*; D011498:Protein Precursors / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D013347:Subcellular Fractions / Q000378:metabolism; D013449:Sulfonamides
chemical_list: D007546:Isoquinolines; D008565:Membrane Proteins; D010455:Peptides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011498:Protein Precursors; D013449:Sulfonamides; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C053177:N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide; D007611:Aprotinin; C043204:N-(2-guanidinoethyl)-5-isoquinolinesulfonamide; C058824:IP 20; D011494:Protein Kinases; D000469:Alkaline Phosphatase; D012697:Serine Endopeptidases; C067404:activator of DNA replication